Literature DB >> 15902747

Mild hypothermia protects liver against ischemia and reperfusion injury.

Cheng-You Wang1, Yong Ni, Yan Liu, Zhi-Heng Huang, Min-Jie Zhang, Yong-Qiang Zhan, Hai-Bin Gao.   

Abstract

AIM: To determine whether mild hypothermia could protect liver against ischemia and reperfusion injury in pigs.
METHODS: Twenty-four healthy pigs were randomly divided into normothermia, mild hypothermia and normal control groups. The experimental procedure consisted of temporary interruption of blood flow to total hepatic lobe for different lengths of time and subsequent reperfusion. Hepatic tissue oxygen pressure (PtiO2) and aspartate aminotransferase (AST) values were evaluated, and ultrastructural analysis was carried out for all samples.
RESULTS: Serum AST was significantly lower, and hepatic PtiO2 values were significantly higher in the mild hypothermia group than in the normothermia group during liver ischemia-reperfusion periods (P=0.032, P=0.028). Meanwhile, the histopathologic injury of liver induced by ischemia-reperfusion was significantly improved in the mild hypothermia group, compared with that in the normothermia group.
CONCLUSION: Mild hypothermia can protect the liver from ischemia-reperfusion injury in pigs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902747      PMCID: PMC4305678          DOI: 10.3748/wjg.v11.i19.3005

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Advantages of normothermic perfusion over cold storage in liver preservation.

Authors:  Charles J Imber; Shawn D St Peter; Inigo Lopez de Cenarruzabeitia; Dave Pigott; Tim James; Richard Taylor; James McGuire; David Hughes; Andrew Butler; Michael Rees; Peter J Friend
Journal:  Transplantation       Date:  2002-03-15       Impact factor: 4.939

Review 2.  New insights into the regulation of hepatic blood flow after ischemia and reperfusion.

Authors:  Benedikt H J Pannen
Journal:  Anesth Analg       Date:  2002-06       Impact factor: 5.108

3.  Role of NF-kappaB on liver cold ischemia-reperfusion injury.

Authors:  Yoshihito Takahashi; Raymond W Ganster; Andrea Gambotto; Lifang Shao; Takashi Kaizu; Tong Wu; Gautam P Yagnik; Atsunori Nakao; George Tsoulfas; Takashi Ishikawa; Toyokazu Okuda; David A Geller; Noriko Murase
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-11       Impact factor: 4.052

4.  Gut ischemia/reperfusion-induced liver dysfunction occurs despite sustained oxygen consumption.

Authors:  R S Poggetti; E E Moore; F A Moore; K Koike; A Banerjee
Journal:  J Surg Res       Date:  1992-05       Impact factor: 2.192

5.  The influence of organ temperature on hepatic ischemia-reperfusion injury: a systematic analysis.

Authors:  P Biberthaler; B Luchting; S Massberg; D Teupser; S Langer; R Leiderer; K Messmer; F Krombach
Journal:  Transplantation       Date:  2001-11-15       Impact factor: 4.939

6.  Protective effect of ischemic preconditioning on liver.

Authors:  Y Zhang; B Zhang; R Pan
Journal:  Chin J Traumatol       Date:  2001-05

7.  Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat.

Authors:  Anna Serafín; Joan Roselló-Catafau; Neus Prats; Carme Xaus; Emilio Gelpí; Carmen Peralta
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

Authors:  B Vollmar; J Glasz; R Leiderer; S Post; M D Menger
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Influence of acidosis and hypoxia on liver ischemia and reperfusion injury in an in vivo rat model.

Authors:  Bob H M Heijnen; Yasser Elkhaloufi; Irene H Straatsburg; Thomas M Van Gulik
Journal:  J Appl Physiol (1985)       Date:  2002-07

10.  Role of microcirculatory derangements in manifestation of portal triad cross-clamping-induced hepatic reperfusion injury.

Authors:  B Vollmar; J Glasz; S Post; M D Menger
Journal:  J Surg Res       Date:  1996-01       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.